Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

AZN

AstraZeneca (AZN)

AstraZeneca PLC

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AZN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
08/01/2024	13h05	PR Newswire (US)	Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer	NASDAQ:AZN	AstraZeneca PLC
03/01/2024	10h25	Dow Jones News	C4X Discovery Shares Rise on AstraZeneca Milestone Payment	NASDAQ:AZN	AstraZeneca PLC
02/01/2024	16h53	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AZN	AstraZeneca PLC
02/01/2024	15h00	PR Newswire (US)	Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca	NASDAQ:AZN	AstraZeneca PLC
27/12/2023	14h03	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:AZN	AstraZeneca PLC
27/12/2023	13h09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AZN	AstraZeneca PLC
27/12/2023	12h08	IH Market News	Wall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and More	NASDAQ:AZN	AstraZeneca PLC
26/12/2023	23h25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AZN	AstraZeneca PLC
26/12/2023	12h44	Dow Jones News	Gracell ADSs Take Flight Premarket on $1.2 Billion Takeover by AstraZeneca	NASDAQ:AZN	AstraZeneca PLC
26/12/2023	09h05	Dow Jones News	AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion	NASDAQ:AZN	AstraZeneca PLC
26/12/2023	08h01	Business Wire	AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases	NASDAQ:AZN	AstraZeneca PLC
22/12/2023	12h19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AZN	AstraZeneca PLC
22/12/2023	01h38	Dow Jones News	Ionis Pharmaceuticals, AstraZeneca Get FDA Approval for Rare Genetic Disease Treatment	NASDAQ:AZN	AstraZeneca PLC
22/12/2023	01h13	Business Wire	WAINUA™ (eplontersen) Granted First-Ever Regulatory Approval in the US for the Treatment of Adults With Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis	NASDAQ:AZN	AstraZeneca PLC
19/12/2023	13h10	PR Newswire (US)	Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer	NASDAQ:AZN	AstraZeneca PLC
12/12/2023	21h46	Dow Jones News	Trending: AstraZeneca Pushes Further Into Vaccines With Deal to Buy Icosavax	NASDAQ:AZN	AstraZeneca PLC
12/12/2023	13h00	Business Wire	AstraZeneca to Acquire Icosavax, Including Potential First-in-class RSV and hMPV Combination Vaccine With Positive Phase II Data	NASDAQ:AZN	AstraZeneca PLC
12/12/2023	12h25	Dow Jones News	Icosavax Shares Take Flight on Takeover by AstraZeneca	NASDAQ:AZN	AstraZeneca PLC
12/12/2023	09h02	Dow Jones News	AstraZeneca to Buy Icosavax for Up to $1.1 Billion -- Update	NASDAQ:AZN	AstraZeneca PLC
12/12/2023	08h47	Dow Jones News	AstraZeneca to Buy Icosavax for Up to $1.1 Billion	NASDAQ:AZN	AstraZeneca PLC
11/12/2023	01h35	Business Wire	Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis	NASDAQ:AZN	AstraZeneca PLC
07/12/2023	13h49	Dow Jones News	Merck Scraps Phase 3 Keytruda-Lynparza Lung Cancer Study	NASDAQ:AZN	AstraZeneca PLC
04/12/2023	16h41	Dow Jones News	Absci Shares Rise 27% After Announcing Collaboration With AstraZeneca	NASDAQ:AZN	AstraZeneca PLC
30/11/2023	14h00	PR Newswire (US)	Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology	NASDAQ:AZN	AstraZeneca PLC
29/11/2023	13h00	Business Wire	AstraZeneca advances scientific leadership in hematology at ASH 2023	NASDAQ:AZN	AstraZeneca PLC
21/11/2023	13h20	Business Wire	AstraZeneca lancia Evinova, un'attività di tecnologia sanitaria per accelerare l'innovazione nel settore delle scienze della salute, la realizzazione di studi clinici e migliori risultati sanitari	NASDAQ:AZN	AstraZeneca PLC
21/11/2023	03h50	Business Wire	AstraZeneca gründet Evinova – das Gesundheitstechnologie-Unternehmen wird Innovationen im Biowissenschaftssektor, die Durchführung klinischer Studien und bessere Behandlungsergebnisse beschleunigen	NASDAQ:AZN	AstraZeneca PLC
21/11/2023	01h44	Business Wire	AstraZeneca lance Evinova, une entreprise de technologies de la santé visant à accélérer l’innovation dans le secteur des sciences de la vie, l'exécution d’essais cliniques et l'amélioration des résultats de santé	NASDAQ:AZN	AstraZeneca PLC
20/11/2023	22h57	Business Wire	アストラゼネカ、医療技術ビジネスであるEvinova（エヴィノバ）を立ち上げ、ライフサイエンス分野全体のイノベーション、臨床試験の提供、より良い健康成果を加速	NASDAQ:AZN	AstraZeneca PLC
20/11/2023	14h27	Business Wire	AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes	NASDAQ:AZN	AstraZeneca PLC

Showing the most relevant articles for your search:NASDAQ:AZN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Gold vs US Dollar

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen